Welcome to LookChem.com Sign In|Join Free

CAS

  • or

262376-01-2

Post Buying Request

262376-01-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

262376-01-2 Usage

General Description

[4-(4-AMINO-PHENYL)-PIPERAZIN-1-YL]-P-TOLYL-METHANONE is a chemical compound with the molecular formula C18H22N4O. It is a piperazine derivative that contains both an amino group and a tolyl group. [4-(4-AMINO-PHENYL)-PIPERAZIN-1-YL]-P-TOLYL-METHANONE is often used as a building block in organic synthesis and medicinal chemistry. It has been studied for its potential pharmacological properties, including its role in modulating the central nervous system and its potential as a drug lead for the treatment of various conditions. The compound’s structure and properties make it a valuable and versatile component in the development of new drugs and research in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 262376-01-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,2,3,7 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 262376-01:
(8*2)+(7*6)+(6*2)+(5*3)+(4*7)+(3*6)+(2*0)+(1*1)=132
132 % 10 = 2
So 262376-01-2 is a valid CAS Registry Number.

262376-01-2Upstream product

262376-01-2Downstream Products

262376-01-2Relevant articles and documents

Phenylpiperazine type UBE2F small molecule inhibitor and synthesis method thereof

-

Paragraph 0034-0035; 0042-0043; 0100-0102, (2019/09/14)

The invention discloses a phenylpiperazine type UBE2F small molecule inhibitor and a synthesis method thereof, discloses a phenylpiperazine type compound represented by the general formula I or a pharmaceutically acceptable salt thereof, and further discloses a synthesis route of the general formula I and a synthesis method of each step. As a small molecule inhibitor target at UBE2F, that phenylpiperazine type compound of the present invention effectively suppresses the growth of tumor cell by preventing the G2/M process of cell cycle and inducing apoptosis of human tumor cells. Therefore, thecompound is a new class of specific anti-tumor drugs by targeting UBE2F.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 262376-01-2